Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

C7 intra-laminar screws for complex cervicothoracic spine surgery-a case series.

Wilson PJ, Selby MD.

J Spine Surg. 2017 Dec;3(4):561-566. doi: 10.21037/jss.2017.10.05.

2.

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models.

Lewis KE, Selby MJ, Masters G, Valle J, Dito G, Curtis WR, Garcia R, Mink KA, Waggie KS, Holdren MS, Grosso JF, Korman AJ, Jure-Kunkel M, Dillon SR.

Oncoimmunology. 2017 Oct 4;7(1):e1377873. doi: 10.1080/2162402X.2017.1377873. eCollection 2017.

3.

Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model.

Shen YC, Ghasemzadeh A, Kochel CM, Nirschl TR, Francica BJ, Lopez-Bujanda ZA, Carrera Haro MA, Tam A, Anders RA, Selby MJ, Korman AJ, Drake CG.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):113-125. doi: 10.1038/s41391-017-0013-x. Epub 2017 Dec 4.

PMID:
29203894
4.

CT guided radiofrequency ablation of the cervical medial branch using a lateral approach in the supine patient.

Nguyen T, Chan K, Chryssidis S, Selby M.

J Spine Surg. 2017 Sep;3(3):463-467. doi: 10.21037/jss.2017.06.18. No abstract available.

5.

TAp73 is a marker of glutamine addiction in medulloblastoma.

Niklison-Chirou MV, Erngren I, Engskog M, Haglöf J, Picard D, Remke M, McPolin PHR, Selby M, Williamson D, Clifford SC, Michod D, Hadjiandreou M, Arvidsson T, Pettersson C, Melino G, Marino S.

Genes Dev. 2017 Sep 1;31(17):1738-1753. doi: 10.1101/gad.302349.117. Epub 2017 Sep 26.

6.

Cucurbit extrafascicular phloem has strong negative impacts on aphids and is not a preferred feeding site.

Kanvil S, Pham J, Lopez-Cobollo R, Selby M, Bennett M, Beckingham C, Powell G, Turnbull C.

Plant Cell Environ. 2017 Nov;40(11):2780-2789. doi: 10.1111/pce.13053. Epub 2017 Sep 27.

PMID:
28779505
7.

Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent.

Teicher BA, Silvers T, Selby M, Delosh R, Laudeman J, Ogle C, Reinhart R, Parchment R, Krushkal J, Sonkin D, Rubinstein L, Morris J, Evans D.

Cancer Med. 2017 Aug;6(8):1952-1964. doi: 10.1002/cam4.1131. Epub 2017 Aug 1.

8.

Most Cited Publications in Cervical Spine Surgery.

Lee YC, Brooks F, Sandler S, Yau YH, Selby M, Freeman B.

Int J Spine Surg. 2017 Jun 28;11:19. doi: 10.14444/4019. eCollection 2017.

9.

3D Models of the NCI60 Cell Lines for Screening Oncology Compounds.

Selby M, Delosh R, Laudeman J, Ogle C, Reinhart R, Silvers T, Lawrence S, Kinders R, Parchment R, Teicher BA, Evans DM.

SLAS Discov. 2017 Jun;22(5):473-483. doi: 10.1177/2472555217697434. Epub 2017 Mar 13.

PMID:
28288283
10.

Evolution of the hominoid scapula and its implications for earliest hominid locomotion.

Selby MS, Lovejoy CO.

Am J Phys Anthropol. 2017 Apr;162(4):682-700. doi: 10.1002/ajpa.23158. Epub 2017 Jan 27.

PMID:
28128440
11.

Spinal cord compression from Wegener's granulomatosis: an unusual presentation.

Roy D, Rao PJ, Phan K, Mobbs RJ, Selby M.

J Spine Surg. 2016 Dec;2(4):319-323. doi: 10.21037/jss.2016.12.03.

12.

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape.

Noguchi T, Ward JP, Gubin MM, Arthur CD, Lee SH, Hundal J, Selby MJ, Graziano RF, Mardis ER, Korman AJ, Schreiber RD.

Cancer Immunol Res. 2017 Feb;5(2):106-117. doi: 10.1158/2326-6066.CIR-16-0391. Epub 2017 Jan 10.

13.

Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.

Selby MJ, Engelhardt JJ, Johnston RJ, Lu LS, Han M, Thudium K, Yao D, Quigley M, Valle J, Wang C, Chen B, Cardarelli PM, Blanset D, Korman AJ.

PLoS One. 2016 Nov 18;11(11):e0167251. doi: 10.1371/journal.pone.0167251. eCollection 2016.

14.

Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.

Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M.

J Immunother Cancer. 2016 Nov 4;4:74. doi: 10.1186/s40425-016-0181-6. eCollection 2016.

15.

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.

Selby MJ, Engelhardt JJ, Johnston RJ, Lu LS, Han M, Thudium K, Yao D, Quigley M, Valle J, Wang C, Chen B, Cardarelli PM, Blanset D, Korman AJ.

PLoS One. 2016 Sep 9;11(9):e0161779. doi: 10.1371/journal.pone.0161779. eCollection 2016. Erratum in: PLoS One. 2016 Nov 18;11(11):e0167251.

16.

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.

Polley E, Kunkel M, Evans D, Silvers T, Delosh R, Laudeman J, Ogle C, Reinhart R, Selby M, Connelly J, Harris E, Fer N, Sonkin D, Kaur G, Monks A, Malik S, Morris J, Teicher BA.

J Natl Cancer Inst. 2016 May 31;108(10). doi: 10.1093/jnci/djw122. Print 2016 Oct.

PMID:
27247353
17.

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.

Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M.

J Immunother Cancer. 2016 May 17;4:28. doi: 10.1186/s40425-016-0132-2. eCollection 2016. Erratum in: J Immunother Cancer. 2016 Nov 4;4:74.

18.

Total Synthesis of (-)-Luminacin D.

Malassis J, Bartlett N, Hands K, Selby MD, Linclau B.

J Org Chem. 2016 May 6;81(9):3818-37. doi: 10.1021/acs.joc.6b00489. Epub 2016 Apr 19.

19.

The Functional Anatomy of the Carpometacarpal Complex in Anthropoids and Its Implications for the Evolution of the Hominoid Hand.

Selby MS, Simpson SW, Lovejoy CO.

Anat Rec (Hoboken). 2016 May;299(5):583-600. doi: 10.1002/ar.23333. Epub 2016 Mar 15.

20.

Molecular hybridization yields triazole bronchodilators for the treatment of COPD.

Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5121-6. doi: 10.1016/j.bmcl.2015.10.008. Epub 2015 Oct 8.

PMID:
26471092
21.

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.

Dahan R, Sega E, Engelhardt J, Selby M, Korman AJ, Ravetch JV.

Cancer Cell. 2015 Oct 12;28(4):543. doi: 10.1016/j.ccell.2015.09.011. Epub 2015 Oct 12. No abstract available.

22.

Epidural abscess from prolotherapy: a cautionary tale.

Clifton T, Selby M.

ANZ J Surg. 2018 Mar;88(3):E216-E217. doi: 10.1111/ans.13328. Epub 2015 Sep 30. No abstract available.

PMID:
26424616
23.

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.

Dahan R, Sega E, Engelhardt J, Selby M, Korman AJ, Ravetch JV.

Cancer Cell. 2015 Sep 14;28(3):285-95. doi: 10.1016/j.ccell.2015.08.004. Erratum in: Cancer Cell. 2015 Oct 12;28(4):543.

24.

Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression.

Teicher BA, Polley E, Kunkel M, Evans D, Silvers T, Delosh R, Laudeman J, Ogle C, Reinhart R, Selby M, Connelly J, Harris E, Monks A, Morris J.

Mol Cancer Ther. 2015 Nov;14(11):2452-62. doi: 10.1158/1535-7163.MCT-15-0074. Epub 2015 Sep 8.

25.

Direct evidence of podocyte damage in cardiorenal syndrome type 2: preliminary evidence.

Le Jemtel TH, Rajapreyar I, Selby MG, Payne B, Barnidge DR, Milic N, Garovic VD.

Cardiorenal Med. 2015 Apr;5(2):125-34. doi: 10.1159/000375130. Epub 2015 Feb 28.

26.

Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance.

Lindsey JC, Kawauchi D, Schwalbe EC, Solecki DJ, Selby MP, McKinnon PJ, Olson JM, Hayden JT, Grundy RG, Ellison DW, Williamson D, Bailey S, Roussel MF, Clifford SC.

Oncogene. 2015 Sep 3;34(36):4746-57. doi: 10.1038/onc.2014.405. Epub 2014 Dec 22.

27.

Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events.

Selby MG, Vrtiska TJ, Krambeck AE, McCollough CH, Elsherbiny HE, Bergstralh EJ, Lieske JC, Rule AD.

Urology. 2015 Jan;85(1):45-50. doi: 10.1016/j.urology.2014.08.031. Epub 2014 Oct 22.

28.

Your license at risk: an overview of the Board of Nursing disciplinary process.

Selby M.

Okla Nurse. 2014 Jun-Aug;59(2):4. No abstract available.

PMID:
25033500
29.

What is the current NHS service provision for patients severely affected by chronic fatigue syndrome/myalgic encephalomyelitis? A national scoping exercise.

McDermott C, Al Haddabi A, Akagi H, Selby M, Cox D, Lewith G.

BMJ Open. 2014 Jul 1;4(6):e005083. doi: 10.1136/bmjopen-2014-005083.

30.

In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.

Wang C, Thudium KB, Han M, Wang XT, Huang H, Feingersh D, Garcia C, Wu Y, Kuhne M, Srinivasan M, Singh S, Wong S, Garner N, Leblanc H, Bunch RT, Blanset D, Selby MJ, Korman AJ.

Cancer Immunol Res. 2014 Sep;2(9):846-56. doi: 10.1158/2326-6066.CIR-14-0040. Epub 2014 May 28.

31.

Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.

Selby MJ, Engelhardt JJ, Quigley M, Henning KA, Chen T, Srinivasan M, Korman AJ.

Cancer Immunol Res. 2013 Jul;1(1):32-42. doi: 10.1158/2326-6066.CIR-13-0013. Epub 2013 Apr 7.

32.

Stereocontrol by quaternary centres: a stereoselective synthesis of (-)-luminacin D.

Bartlett N, Gross L, Péron F, Asby DJ, Selby MD, Tavassoli A, Linclau B.

Chemistry. 2014 Mar 17;20(12):3306-10. doi: 10.1002/chem.201304776. Epub 2014 Feb 12.

PMID:
24519660
33.

Seronegative anti-GBM Disease with Coexistent ANCA Positivity.

Ratelle JT, Franco Palacios CR, Selby MG, Franco Palacios M, Fidler ME, Casey ET.

Bull Hosp Jt Dis (2013). 2014;72(4):301-4.

PMID:
25986356
34.

Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice.

Pryde DC, Jones LH, Gervais DP, Stead DR, Blakemore DC, Selby MD, Brown AD, Coe JW, Badland M, Beal DM, Glen R, Wharton Y, Miller GJ, White P, Zhang N, Benoit M, Robertson K, Merson JR, Davis HL, McCluskie MJ.

PLoS One. 2013 Oct 1;8(10):e76557. doi: 10.1371/journal.pone.0076557. eCollection 2013.

35.

Occurrence and risk screening of alcohol ethoxylate surfactants in three U.S. river sediments associated with wastewater treatment plants.

Sanderson H, van Compernolle R, Dyer SD, Price BB, Nielsen AM, Selby M, Ferrer D, Stanton K.

Sci Total Environ. 2013 Oct 1;463-464:600-10. doi: 10.1016/j.scitotenv.2013.05.047. Epub 2013 Jul 6.

36.

A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection.

Gardiner D, Lalezari J, Lawitz E, DiMicco M, Ghalib R, Reddy KR, Chang KM, Sulkowski M, Marro SO, Anderson J, He B, Kansra V, McPhee F, Wind-Rotolo M, Grasela D, Selby M, Korman AJ, Lowy I.

PLoS One. 2013 May 22;8(5):e63818. doi: 10.1371/journal.pone.0063818. Print 2013.

37.

Radiologic assessment of spinal fusion.

Selby MD, Clark SR, Hall DJ, Freeman BJ.

J Am Acad Orthop Surg. 2012 Nov;20(11):694-703. doi: 10.5435/JAAOS-20-11-694.

PMID:
23118135
38.

Noninvasive, quantitative analysis of drug mixtures in containers using spatially offset Raman spectroscopy (SORS) and multivariate statistical analysis.

Olds WJ, Sundarajoo S, Selby M, Cletus B, Fredericks PM, Izake EL.

Appl Spectrosc. 2012 May;66(5):530-7. doi: 10.1366/11-06554.

PMID:
22524958
39.

Synthesis of novel histamine H4 receptor antagonists.

Lane CA, Hay D, Mowbray CE, Paradowski M, Selby MD, Swain NA, Williams DH.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1156-9. doi: 10.1016/j.bmcl.2011.11.098. Epub 2011 Dec 1.

PMID:
22189138
40.

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.

Woo SR, Turnis ME, Goldberg MV, Bankoti J, Selby M, Nirschl CJ, Bettini ML, Gravano DM, Vogel P, Liu CL, Tangsombatvisit S, Grosso JF, Netto G, Smeltzer MP, Chaux A, Utz PJ, Workman CJ, Pardoll DM, Korman AJ, Drake CG, Vignali DA.

Cancer Res. 2012 Feb 15;72(4):917-27. doi: 10.1158/0008-5472.CAN-11-1620. Epub 2011 Dec 20.

41.

Click-enabled heterotrifunctional template for sequential bioconjugations.

Beal DM, Albrow VE, Burslem G, Hitchen L, Fernandes C, Lapthorn C, Roberts LR, Selby MD, Jones LH.

Org Biomol Chem. 2012 Jan 21;10(3):548-54. doi: 10.1039/c1ob06398g. Epub 2011 Nov 21.

PMID:
22101938
42.

In-cell click labelling of small molecules to determine subcellular localisation.

Jones LH, Beal D, Selby MD, Everson O, Burslem GM, Dodd P, Millbank J, Tran TD, Wakenhut F, Graham EJ, Targett-Adams P.

J Chem Biol. 2011 Apr;4(2):49-53. doi: 10.1007/s12154-010-0047-1. Epub 2010 Nov 18.

43.

Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.

Moschos SA, Frick M, Taylor B, Turnpenny P, Graves H, Spink KG, Brady K, Lamb D, Collins D, Rockel TD, Weber M, Lazari O, Perez-Tosar L, Fancy SA, Lapthorn C, Green MX, Evans S, Selby M, Jones G, Jones L, Kearney S, Mechiche H, Gikunju D, Subramanian R, Uhlmann E, Jurk M, Vollmer J, Ciaramella G, Yeadon M.

Mol Ther. 2011 Dec;19(12):2163-8. doi: 10.1038/mt.2011.206. Epub 2011 Oct 4.

44.

Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR).

Masood MA, Selby MD, Bell AS, Mansfield AC, Gardner M, Smith GF, Lane C, Kenyon-Edwards H, Osborne R, Jones RM, Liu WL, Brown CD, Clarke N, Perrucio F, Mowbray CE.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6591-5. doi: 10.1016/j.bmcl.2011.07.114. Epub 2011 Aug 27.

PMID:
21955944
45.

A perspective on synthetic and solid-form enablement of inhalation candidates.

Selby MD, de Koning PD, Roberts DF.

Future Med Chem. 2011 Oct;3(13):1679-701. doi: 10.4155/fmc.11.125. Review.

PMID:
21942256
46.

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist.

Mowbray CE, Bell AS, Clarke NP, Collins M, Jones RM, Lane CA, Liu WL, Newman SD, Paradowski M, Schenck EJ, Selby MD, Swain NA, Williams DH.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6596-602. doi: 10.1016/j.bmcl.2011.07.125. Epub 2011 Aug 9.

PMID:
21920751
47.

Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma.

Millan DS, Ballard SA, Chunn S, Dybowski JA, Fulton CK, Glossop PA, Guillabert E, Hewson CA, Jones RM, Lamb DJ, Napier CM, Payne-Cook TA, Renery ER, Selby MD, Tutt MF, Yeadon M.

Bioorg Med Chem Lett. 2011 Oct 1;21(19):5826-30. doi: 10.1016/j.bmcl.2011.07.106. Epub 2011 Aug 11.

PMID:
21880489
48.

Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3.

Bettini M, Szymczak-Workman AL, Forbes K, Castellaw AH, Selby M, Pan X, Drake CG, Korman AJ, Vignali DA.

J Immunol. 2011 Oct 1;187(7):3493-8. doi: 10.4049/jimmunol.1100714. Epub 2011 Aug 26.

49.

S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.

Sack U, Walther W, Scudiero D, Selby M, Aumann J, Lemos C, Fichtner I, Schlag PM, Shoemaker RH, Stein U.

Mol Biol Cell. 2011 Sep;22(18):3344-54. doi: 10.1091/mbc.E10-09-0739. Epub 2011 Jul 27.

50.

Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.

Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH, Stein U.

J Natl Cancer Inst. 2011 Jul 6;103(13):1018-36. doi: 10.1093/jnci/djr190. Epub 2011 Jun 17.

PMID:
21685359

Supplemental Content

Support Center